» Articles » PMID: 36426345

A 98-Year-Old Male With Paroxysmal Atrial Fibrillation Treated for COVID-19 at Home

Overview
Journal Cureus
Date 2022 Nov 25
PMID 36426345
Authors
Affiliations
Soon will be listed here.
Abstract

In the absence of evidenced-based guidelines for early home treatment of COVID-19, some Italian groups of volunteer physicians (both general practitioners (GPs) and hospital doctors) virtually gathered themselves to discuss the best available evidence and develop shared schemes of therapy. We present the case of a 98-year-old unvaccinated male on chronic anticoagulant therapy with dabigatran for paroxysmal atrial fibrillation (AF), who has been successfully treated for COVID-19 at home, according to one of the multidrug treatments proposed, since hospital admission was not feasible. At the very beginning of symptoms, anti-inflammatory drugs, vitamin D, and adjuvant dietary supplements (quercetin, vitamin C, zinc, and vitamin K2) were administered, followed by dexamethasone and antibiotic therapy, according to the evolving clinical conditions. Gastroprotection with omeprazole was added. Eventually, our patient fully recovered, thus suggesting that careful home assistance under strict medical supervision can be successful, even in a very old subject with comorbidities, particularly if early treatment simultaneously addressing inflammation, hypercoagulation, and viral replication is started.

Citing Articles

The nutritional roles of zinc for immune system and COVID-19 patients.

Jin D, Wei X, He Y, Zhong L, Lu H, Lan J Front Nutr. 2024; 11:1385591.

PMID: 38706559 PMC: 11066294. DOI: 10.3389/fnut.2024.1385591.

References
1.
Fazio S, Cosentino M, Marino F, Pandolfi S, Zanolin E, Bellavite P . The Problem of Home Therapy during COVID-19 Pandemic in Italy: Government Guidelines versus Freedom of Cure?. J Pharm Pharmacol Res. 2023; 6(3):100-114. PMC: 10167757. DOI: 10.26502/fjppr.055. View

2.
Fazio S, Bellavite P, Zanolin E, McCullough P, Pandolfi S, Affuso F . Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis of Early COVID-19 and Treated at Home Within 3 Days or After 3 Days of Symptom Onset with Prescribed and Non-Prescribed Treatments Between.... Med Sci Monit. 2021; 27:e935379. PMC: 8725339. DOI: 10.12659/MSM.935379. View

3.
DI Pierro F, Iqtadar S, Khan A, Mumtaz S, Masud Chaudhry M, Bertuccioli A . Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial. Int J Gen Med. 2021; 14:2807-2816. PMC: 8238537. DOI: 10.2147/IJGM.S318949. View

4.
Perico N, Cortinovis M, Suter F, Remuzzi G . Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents. Lancet Infect Dis. 2022; 23(1):e22-e33. PMC: 9411261. DOI: 10.1016/S1473-3099(22)00433-9. View

5.
DI Pierro F, Derosa G, Maffioli P, Bertuccioli A, Togni S, Riva A . Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study. Int J Gen Med. 2021; 14:2359-2366. PMC: 8197660. DOI: 10.2147/IJGM.S318720. View